| ACA | Anti-centromere antibodies |
| ACPA | Anti-citrullinated protein antibodies |
| ACR | American College of Rheumatology |
| AECG | American European Consensus Group |
| AH | Autoimmune Hepatitis |
| ANA | Antinuclear antibodies |
| anti-M3R | Anti-muscarinic receptor 3 |
| APRIL | A proliferation-inducing ligand |
| ASAP | “Abatacept Sjögren Active Patients” study |
| AZA | Azathioprine |
| BAFF | B cell Activating Factor |
| BCR | B cell receptor |
| BUT | Break-up Time |
| CCP | Cyclic Citrullinated Peptide |
| circRNA | Circular RNA |
| ciRNAs | Intronic circRNAs |
| ClinESSDAI | Clinical ESSDAI variant |
| CPK | Creatine phosphokinase |
| CRISP-3 | Cysteine-Rich Secretory Protein 3 () |
| CT-scan | Computerized tomography |
| CyA | Ciclosporin A |
| DAMPS | Danger-associated molecular patterns |
| DAP-kinase | Pro-apoptotic death associated protein kinase |
| DHEA | Dehydroepiandrosterone |
| DHT | Dihydrotestosterone |
| DLBCL | Diffuse large B cell lymphoma |
| DMARD | Disease Modifying Anti-Rheumatic Drug |
| DNMTs | DNA methyltransferases |
| DREAM | “Dry Eye Assessment and Management” study |
| EBV | Epstein-Barr virus |
| ecircRNAs | Exonic circRNAs |
| EIciRNAs | Exon-intron circRNAs |
| ELISA | Enzyme-linked immunosorbent assay |
| ENT | Ear-Nose-Throat |
| ESSDAI | EULAR Sjögren’s syndrome disease activity index |
| ESSPRI | EULAR Sjögren’s Syndrome Patient Reported Index |
| EULAR | European League Against Rheumatism |
| FASl | Fas ligand |
| FDC | Follicular dendritic cells |
| GCs | Germinal centres |
| HCQ | Hydroxychloroquine |
| HCV | Hepatitis C virus |
| HLH | Hemophagocytic lymphohistiocytosis |
| HTLV1 | Human T-lymphotropic virus type I |
| ICAM-1 | InterCellular Adhesion Molecule 1 |
| IF | Immunofluorescence |
| IFN | Interferon |
| IgG,A,M | Immunoglobulin G, A and M |
| IL- | Interleukin |
| ILD | Interstitial lung disease(s) |
| IRF | Interferon Regulatory Factor |
| IV | Intravenous therapy |
| IVIG | Intravenous Immunoglobulin |
| KCS | Keratoconjunctivitis sicca |
| LEMA | Myoepithelial sialadenitis |
| LESA | lymphoepithelial sialadenitis |
| LIP | Lymphocytic interstitial pneumonitis |
| LMP1 | Latent membrane protein 1 |
| lncRNA | Long non-coding RNAs |
| LPR | Laryngopharyngeal reflux |
| LSG | Labial SG |
| MALT | mucosa-associated lymphoid tissue |
| MHC | Major histocompatibility genes |
| MMF | Mycophenolate mofetil |
| MMP | Matrix metalloproteinases |
| MPGN | Mesangioproliferative glomerulonephritis |
| MRI | Magnetic Resonance Imaging |
| MS | Multiple Sclerosis |
| MSGB | Minor salivary gland biopsy |
| MTX | Methotrexate |
| NAC | N-acetylcystein |
| NFkB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NHL | Non-Hodgkin’s lymphoma |
| NICE | National Institute for Health and Care Excellence |
| NMOSD | Neuromyelitis optica spectrum disorder |
| NOD | Non-obese diabetic |
| NSAID | Nonsteroidal anti-inflammatory drugs |
| NSIP | Nonspecific interstitial pneumonia |
| OMERACT | Outcome Measures in Rheumatology group |
| OSDI | Ocular Surface Disease Index |
| OSS | Ocular Staining Score |
| PAMPs | Pathogen-associated molecular patterns |
| PBC | Primary Biliary Cirrhosis |
| PDC | Plasmacytoid dendritic cells |
| PDL1 | Programmed death ligand 1 |
| PET scan | Positron emission tomography |
| PGA | Patient Global Assessment |
| PIP | Prolactin inducible protein |
| PO | per os |
| PSP | Parotid secretory protein |
| pSS | Primary Sjögren’s Syndrome |
| pSS-ILD | pSS-related interstitial lung disease |
| q6h, q8h | Every 6 h, every 8 h |
| RA | Rheumatoid Arthritis |
| RCT | Randomized controlled trial |
| RF | Rheumatoid Factor |
| RTA | Renal tubular acidosis |
| RTX | Rituximab |
| RX1 | Runt-related transcription factor |
| SAM | Methyl donor S-adenosylmethionine |
| SAP | Sicca Asthenia Polyalgia |
| SF-36 | Short Form 36 health survey |
| SG | Salivary Gland |
| SGS | Salivary glands scintigraphy |
| SGUS | Salivary glands ultrasound |
| SICCA | Sjögren’s International Collaborative Clinical Alliance |
| SLE | Systemic lupus erythematosus |
| SNP | Single nucleotide polymorphism |
| SP-1 | Salivary protein 1 |
| SSDDI | Sjögren’s Syndrome Disease Damage Index |
| SSDI | Sjögren’s Syndrome Damage Index |
| sSS | Secondary Sjögren’s Syndrome |
| SWSF | Stimulated Whole Salivary Flow rate |
| TACI | Transmembrane Activator and CAML Interactor |
| TEARS | “Tolerance and efficacy of rituximab in primary Sjögren syndrome” trial |
| Tfh | Follicular helper T cells |
| TLRs | Toll Like Receptors |
| TNF-α | Tumour necrosis factor-α |
| TPHA | Treponema Pallidum Hemagglutinations Assay |
| TRACTISS | “TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome” trial |
| TSH | Thyroid-stimulating hormone |
| TTP | Thrombotic Thrombocytopenic Purpura |
| UCLH | University College London Hospitals |
| UIP | Usual interstitial pneumonia |
| UWSF | Unstimulated Whole Saliva Flow rate |
| VAS | Visual analogue scales |
| VDRL | Venereal Disease Research Laboratory |